Back to LLY
Grantham, Mayo, Van Otterloo & Co. LLC → LLY
Grantham, Mayo, Van Otterloo & Co. LLC LLY Position History
Eli Lilly and Company • Healthcare
Quarters held
14
Latest value
$892.3M
Q2 2026
Peak value
$892.3M
First seen
Q1 2023
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2023 | $270.6M |
| Q2 2023 | $382.8M |
| Q3 2023 | $354.2M |
| Q4 2023 | $402.1M |
| Q1 2024 | $532M |
| Q2 2024 | $426M |
| Q3 2024 | $379.9M |
| Q4 2024 | $336M |
| Q1 2025 | $399.6M |
| Q2 2025 | $369.5M |
| Q3 2025 | $534.6M |
| Q4 2025 | $794.5M |
| Q1 2026 | $689.7M |
| Q2 2026 | $892.3M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $892.3M | 744.0K | — | — |
| Q1 2026 | $689.7M | 749.8K | — | — |
| Q4 2025 | $794.5M | 739.3K | — | — |
| Q3 2025 | $534.6M | 700.6K | — | — |
| Q2 2025 | $369.5M | 474.0K | — | — |
| Q1 2025 | $399.6M | 483.8K | — | — |
| Q4 2024 | $336M | 435.2K | — | — |
| Q3 2024 | $379.9M | 428.9K | — | — |
| Q2 2024 | $426M | 470.5K | — | — |
| Q1 2024 | $532M | 683.8K | — | — |
| Q4 2023 | $402.1M | 689.9K | — | — |
| Q3 2023 | $354.2M | 659.5K | — | — |
| Q2 2023 | $382.8M | 816.3K | — | — |
| Q1 2023 | $270.6M | 787.8K | — | — |
Other funds holding LLY
$108.4B
$104.2B
$99.1B
$84.5B
$79.5B
$72.9B
$62.3B
$59.7B